Topics

Articles

Innovation and investment in advancing lifesaving therapies for pediatric patients to the commercial stage remains a daunting task, but rapid advances today in modeling and simulation are reducing the hurdles for drugmakers.

Pediatric Medicine: Challenges Abound

With the rapid rise of the specialty drug market, manufacturers are increasingly relying on new advances used by patient hubs to boost their levels of patient engagement.

High-Tech Hubs and Specialty Pharma

Deciphering the different "technology-first” and “technology-enabled” patient   support programs.

What is a Digital Hub in 2023?

How personalized interventions can help boost the omnichannel experience for patient hubs—and drive engagement and impact adherence in outcomes.

Patient Hubs in an Omnichannel World

With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.

Fresenius Kabi Introduces Unit-of-Use 2D Barcodes 

As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

Disruptive Factors Shape RA Landscape

How artificial intelligence and real-world data has not just helped predict patient behavior, but has also been successful at the point-of-care for life sciences companies.  

Applying AI Case Studies in Pharma 

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients

The Value of ML in Customer Targeting

How privacy and technology literacy can coexist behind a blockchain-based approach  to patient data analytics and control   

Patient Data: Solving Ownership Question

How artificial intelligence is improving the patient experience

Patient Support